Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan:9:e2200358.
doi: 10.1200/GO.22.00358.

Mammography Coverage in Brazil and the Presidential Elections: Is There Anything to Celebrate?

Ruffo Freitas-Junior  1   2 , Aline Ferreira Bandeira de Melo Rocha  3 , Leonardo Ribeiro Soares  1
Affiliations

Mammography Coverage in Brazil and the Presidential Elections: Is There Anything to Celebrate?

Ruffo Freitas-Junior et al. JCO Glob Oncol. 2023 Jan.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated unless otherwise noted. Relationships are self-held unless noted. I = Immediate Family Member, Inst = My Institution. Relationships may not relate to the subject matter of this manuscript. For more information about ASCO's conflict of interest policy, please refer to www.asco.org/rwc or ascopubs.org/go/authors/author-center.

Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments).

Ruffo Freitas-Junior

Honoraria: Libbs, Pfizer, MSD/AstraZeneca, Zeiss

Consulting or Advisory Role: Novartis, MSD Oncology

Research Funding: Roche (Inst), MSD (Inst), Novartis Biociencias (Inst), Sanofi (Inst)

Travel, Accommodations, Expenses: Libbs, MSD/AstraZeneca

Leonardo Ribeiro Soares

Honoraria: MSD Oncology

Speakers' Bureau: Roche

Travel, Accommodations, Expenses: MSD Oncology

No other potential conflicts of interest were reported.

Figures

FIG 1
FIG 1
Breast cancer screening coverage (%) in Brazil in women age 50-69 years, clients of the public health care system, according to the president in power at the time.
See this image and copyright information in PMC

References

    1. The Lancet: New beginnings for Latin America? Lancet 400:707, 2022 - PMC - PubMed
    1. Migowski A, Azevedo e Silva G, Dias MBK, et al. : Guidelines for early detection of breast cancer in Brazil. II – New national recommendations, main evidence, and controversies. Cad Saude Publica 34:1-16, 2018 - PubMed
    1. INCA : Parâmetros técnicos para rastreamento do câncer de mama. Rio de Janeiro, INCA, 2021. https://www.inca.gov.br/sites/ufu.sti.inca.local/files//media/document/p...
    1. WHO : Cancer Control: Knowledge Into Action: WHO Guide for Effective Programmes: Early Detection. Geneva, Switzerland, World Health Organization, 2007, pp 3-39. https://www.ncbi.nlm.nih.gov/books/n/whocancer3/pdf/ - PubMed
    1. IARC : Brazil Source: Globocan Incidence, Mortality and Prevalence by Cancer Site. Lyon, France, The Global Cancer Observatory, 2021, pp 1–2. https://gco.iarc.fr/today/data/factsheets/populations/76-brazil-fact-she...

Publication types